Compare MIST & HYMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIST | HYMC |
|---|---|---|
| Founded | 2003 | N/A |
| Country | Canada | United States |
| Employees | 33 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 648.5M |
| IPO Year | N/A | N/A |
| Metric | MIST | HYMC |
|---|---|---|
| Price | $2.10 | $25.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 10.0M | 3.7M |
| Earning Date | 11-12-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.63 | $1.99 |
| 52 Week High | $3.06 | $29.80 |
| Indicator | MIST | HYMC |
|---|---|---|
| Relative Strength Index (RSI) | 42.75 | 82.38 |
| Support Level | $1.90 | $24.03 |
| Resistance Level | $2.22 | $29.80 |
| Average True Range (ATR) | 0.33 | 2.13 |
| MACD | -0.07 | 1.37 |
| Stochastic Oscillator | 33.20 | 75.81 |
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
Hycroft Mining Holding Corp is a gold and silver producer. Its operating mine, the Hycroft Mine, is an open-pit heap leach operation located approximately fifty four miles west of Winnemucca, Nevada.